2013
DOI: 10.1101/cshperspect.a016949
|View full text |Cite
|
Sign up to set email alerts
|

Endocytosis and Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
313
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 340 publications
(316 citation statements)
references
References 174 publications
(146 reference statements)
3
313
0
Order By: Relevance
“…These alterations include global changes in trafficking networks, and altered trafficking of receptor tyrosine kinases and integrins (Mellman and Yarden, 2013). Intuitively, it might be imagined that such trafficking changes will also include an increased turnover and destruction of ECM components by endocytosis, which will, in turn, favor invasion and metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…These alterations include global changes in trafficking networks, and altered trafficking of receptor tyrosine kinases and integrins (Mellman and Yarden, 2013). Intuitively, it might be imagined that such trafficking changes will also include an increased turnover and destruction of ECM components by endocytosis, which will, in turn, favor invasion and metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Endocytosis plays a critical role in cancer development and treatment (Mellman and Yarden 2013). By mediating selective vesicular packaging of cell surface proteins, including receptors for growth factors, cytokines, and adhesion components, endocytosis regulates the levels of key cancer drivers by regulating their degradation in lysosomes or recycling back to the plasma membrane.…”
Section: Discussionmentioning
confidence: 99%
“…In cancer cells, p53 and RAS have been shown to modulate these endocytotic pathways. 4,20,39 Mutant forms of p53 or altered response to activated receptor tyrosine kinases may modulate the endocytotic response to low pO 2 . 4 …”
mentioning
confidence: 99%